Mutational Study of RAS Subfamily 2CE2 Domain and Fosfestrol as an Ideal Drug Candidate against NSCLC
2017 ◽
Vol 6
(12)
◽
pp. 1898-1901
2001 ◽
Vol 14
(4)
◽
pp. 266-271
◽
2020 ◽
Vol 26
(36)
◽
pp. 4675-4684
◽
2019 ◽
Vol 20
(4)
◽
pp. 285-292
◽
2017 ◽
Vol 14
(4)
◽
pp. 393-402
◽
2020 ◽
Vol 20
(12)
◽
pp. 1093-1104
◽
2014 ◽
Vol 11
(7)
◽
pp. 825-832
◽